Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication - CIRI - Bases moléculaires de la pathogénicité virale Accéder directement au contenu
Article Dans Une Revue Viruses Année : 2015

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication

Résumé

The current outbreak of Ebola virus (EBOV) in West Africa has claimed the lives of more than 15,000 people and highlights an urgent need for therapeutics capable of preventing virus replication. In this study we screened known nucleoside analogues for their ability to interfere with EBOV replication. Among them, the cytidine analogue β-d-N4-hydroxycytidine (NHC) demonstrated potent inhibitory activities against EBOV replication and spread at non-cytotoxic concentrations. Thus, NHC constitutes an interesting candidate for the development of a suitable drug treatment against EBOV.

Dates et versions

hal-01911432 , version 1 (02-11-2018)

Identifiants

Citer

Olivier Reynard, Xuan-Nhi Nguyen, Nathalie Alazard-Dany, Véronique Barateau, Andrea Cimarelli, et al.. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses, 2015, 7 (12), pp.6233-6240. ⟨10.3390/v7122934⟩. ⟨hal-01911432⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More